Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
Location status: Recruiting
Location contact
Ruquan Han, M.D., Ph.D
CONTACT
Ruquan Han, M.D., Ph.D
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06009315
Stroke is the leading cause of disability-adjusted life years (DALYs) in China, imposing a heavy burden on society and families. Endovascular therapy (EVT) has opened the 2.0 era of acute ischemic stroke (AIS) treatment, but still up to 1/3 of patients have poor neurological prognosis. The results of several studies at home and abroad and by our team indicate that anesthesia method and perioperative management are one of the key factors affecting the neurological prognosis of EVT treatment in AIS patients. Based on machine learning big data analysis methods, a prognostic model for EVT treatment of AIS patients can be established to guide individualized treatment decisions. Current prediction models only include patients' baseline variables, and lack the inclusion of intraoperative (anesthesia management and interventional process) and postoperative (intensive monitoring treatment) variables, which limits the clinical application of prediction tools. We will establish a large prospective cohort database including preoperative, intraoperative, and postoperative variables, integrate heterogeneous information from multiple sources based on artificial intelligence machine learning algorithms, and build prognostic prediction models with better clinical applicability and calibration, with the aim of optimizing perioperative management of endovascular therapy, guiding individualized clinical decision-making, and improving patients' clinical prognosis.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Beijing, Beijing Municipality, 100070, China
Location status: Recruiting
Ruquan Han, M.D., Ph.D
CONTACT
Ruquan Han, M.D., Ph.D
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 90±7days after treatment
modified Rankin Scale of 0-2
Contact information is provided by the study sponsor or research team.
Beijing Tiantan Hospital
Other
Development and Validation for Prognostic Prediction Model of Patients With AcUte Stroke undeRgoing EndOvascular TheRApy (AURORA)
Acronym: AURORA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07599904
Acute Ischemic Stroke, Brain Diseases
Flint, Michigan, United States
View Trial DetailsNCT07049692
Acute Ischemic Stroke, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07361302
Acute Ischemic Stroke, Brain Diseases
Buenos Aires, Argentina
View Trial DetailsNCT07347665
Acute Ischemic Stroke, Acute Ischemic Stroke (AIS) Related to a Distal Occlusion
Nishinomiya, Hyōgo, Japan
View Trial Details